A fully integrated solution built to support the unique and fast-paced demands of outpatient therapy clinics. CANTON, Mass.–(BUSINESS WIRE)–MEDITECH today announcedA fully integrated solution built to support the unique and fast-paced demands of outpatient therapy clinics. CANTON, Mass.–(BUSINESS WIRE)–MEDITECH today announced

MEDITECH Announces Expanse Outpatient Therapy

A fully integrated solution built to support the unique and fast-paced demands of outpatient therapy clinics.

CANTON, Mass.–(BUSINESS WIRE)–MEDITECH today announced the release of Expanse Outpatient Therapy, an extension of its Ambulatory solution, designed to transform the operational and clinical experience for physical, occupational, and speech therapy clinics. With an aging population and an increase in chronic conditions, the market for outpatient therapy continues to experience significant growth, driving a growing demand for efficient, cost-effective, and optimized workflows. By fully integrating specialized therapy needs into the native Expanse EHR, MEDITECH is empowering clinics to move beyond fragmented workflows and focus on what matters most — improving patient outcomes and community health.

Expanse Outpatient Therapy aligns with the unique needs of therapy practices. Therapists can view documentation across the full episode of care within their clinical workflows. This integration allows them to easily link treatments, monitor approved and remaining visits, and track therapy cap information, all to better support the patient’s plan of care.

“Expanse Outpatient Therapy is an intuitive solution designed to efficiently manage therapist workflow, enabling clinicians to reclaim valuable time,” said MEDITECH Manager of Product Management Jennifer Ford. “By providing a holistic view of patient activity and integrated clinical guidance, we are helping clinics simplify the complexities of therapy — from documentation to patient interaction.”

Expanse Outpatient Therapy drives impact across the care continuum by supporting the following:

  • Clinical Excellence through Integration: Therapists gain a comprehensive, longitudinal view of the patient’s journey, allowing them to align treatments with real-time patient data to support the full episode of care.
  • Operational Agility: By automating administrative burdens and streamlining scheduling, the solution empowers front-office and clinical teams to achieve the speed and flexibility essential for managing a fast-paced outpatient environment.
  • Optimized Financial Performance: Seamless connectivity between clinical documentation and the back office maximizes reimbursement and ensures compliance with complex therapy regulations.
  • Patient Empowerment: From digital intake forms and virtual visits to appointment reminders and a patient-facing calendar, the solution keeps patients connected and on track with their recovery journey.
  • Data-Driven Growth: Integrated analytics provide leadership with actionable insights into areas like productivity and clinic throughput, offering a clear roadmap for improving patient engagement and scaling the practice.

“By simplifying the administrative side of healthcare, we are enabling clinics to manage every aspect of their business with greater precision,” said MEDITECH Product Manager Pamela Crandall, MS, CCC/SLP. “Our goal is to provide the tools that give therapists more time to focus on their patients and the communities they serve.”

Visit MEDITECH at booth #5031 during HIMSS 2026 to learn more about how MEDITECH is redefining the outpatient therapy clinic experience.

About MEDITECH

MEDITECH empowers healthcare organizations to expand their vision of what’s possible with Expanse, the intelligent EHR platform you can trust. Expanse transforms care and ushers health systems of all sizes into the future with AI-infused solutions, personalized workflows, next-level interoperability, and predictive analytics — all working together to drive better outcomes. See why thousands of healthcare organizations in 29 countries and territories have chosen Expanse. Visit ehr.meditech.com and follow us on YouTube, LinkedIn, X/Twitter, Facebook, Instagram, and Threads.

Contacts

Rose McCarthy

Public Relations and Media Relations Manager

MEDITECH

rmccarthy@meditech.com

Market Opportunity
MASS Logo
MASS Price(MASS)
$0.0003052
$0.0003052$0.0003052
-5.74%
USD
MASS (MASS) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?

Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?

The post Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now? appeared on BitcoinEthereumNews.com. On the lookout for a Sector – Tech fund? Starting with Putnam Global Technology A (PGTAX – Free Report) should not be a possibility at this time. PGTAX possesses a Zacks Mutual Fund Rank of 4 (Sell), which is based on various forecasting factors like size, cost, and past performance. Objective We note that PGTAX is a Sector – Tech option, and this area is loaded with many options. Found in a wide number of industries such as semiconductors, software, internet, and networking, tech companies are everywhere. Thus, Sector – Tech mutual funds that invest in technology let investors own a stake in a notoriously volatile sector, but with a much more diversified approach. History of fund/manager Putnam Funds is based in Canton, MA, and is the manager of PGTAX. The Putnam Global Technology A made its debut in January of 2009 and PGTAX has managed to accumulate roughly $650.01 million in assets, as of the most recently available information. The fund is currently managed by Di Yao who has been in charge of the fund since December of 2012. Performance Obviously, what investors are looking for in these funds is strong performance relative to their peers. PGTAX has a 5-year annualized total return of 14.46%, and is in the middle third among its category peers. But if you are looking for a shorter time frame, it is also worth looking at its 3-year annualized total return of 27.02%, which places it in the middle third during this time-frame. It is important to note that the product’s returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund’s [%] sale charge. If sales charges were included, total returns would have been lower. When looking at a fund’s performance, it…
Share
BitcoinEthereumNews2025/09/18 04:05
QNT Technical Analysis Jan 21

QNT Technical Analysis Jan 21

The post QNT Technical Analysis Jan 21 appeared on BitcoinEthereumNews.com. QNT’s MACD histogram showing a positive trend and RSI stabilizing in the neutral zone
Share
BitcoinEthereumNews2026/01/21 23:54
SHIB Alert: First Three-Hour Death Cross Flashes on Chart in 2026, Is It Important?

SHIB Alert: First Three-Hour Death Cross Flashes on Chart in 2026, Is It Important?

The post SHIB Alert: First Three-Hour Death Cross Flashes on Chart in 2026, Is It Important? appeared on BitcoinEthereumNews.com. Shiba Inu is forming a death cross
Share
BitcoinEthereumNews2026/01/22 00:26